Third Dose Of AstraZeneca COVID-19 Vaccine Boosts Immune Response, Study Suggests

The New York Times (6/28, Robbins) reports, “A third dose of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford generated a strong immune response in clinical trial volunteers, Oxford researchers reported on Monday.” The data have...